Baricitinib Maintains Established Safety Profile - MD Magazine
Baricitinib Maintains Established Safety Profile MD Magazine
Assorted trials and a long-term exposure study of 3770 patients with rheumatoid arthritis further demonstrate baricitinib's previously recorded safety profile.
Comments
Post a Comment